Compare Injective (INJ) vs Saros (SAROS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Injective vs Saros — how do they compare? Injective trades at Rp92,698 (market cap Rp9,18T, Rp1,72T 24h volume), while Saros trades at Rp8.86 (market cap Rp29,79M, Rp14,88M 24h volume). The key difference: Injective is far larger — about 308157.1× Saros's market cap, and Saros's supply is capped (3,5B / 10B SAROS (36%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 36 Days and Saros for 21 Days on average.
| INJ | SAROS | |
|---|---|---|
Market Cap | Rp9,18T | Rp29,79M |
Volume (24h) | Rp1,72T | Rp14,88M |
Circulating Supply | 100M INJ | 3,5B / 10B SAROS (36%) |
Typical Hold Time | 36 Days | 21 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Injective (INJ) is trading at Rp92,221 with a market cap of Rp9.18T, showing a bullish technical signal overall. The moving averages are strongly bullish, while oscillators are neutral. Key resistance lies at Rp93,589 and support at Rp86,188. The asset has a hold time of 36 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are noted recently, but the token remains active in decentralized exchange and DeFi sectors.
Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential consolidation. Opportunities lie in continued ecosystem growth, while major risks involve crypto market sentiment shifts and regulatory uncertainties. Investors should monitor key resistance levels for breakout signals.
Saros (SAROS) is currently trading at Rp7.49 with a market cap of Rp25.22M, showing a bearish technical signal as indicated by moving averages. The asset has a circulating supply of 3.5M tokens out of a maximum 10M, with a circulation rate of 36%. Key technical indicators show neutral oscillators and mixed signals from RSI and ADX. No major protocol updates or ecosystem developments have been reported recently.
Overall outlook remains cautious due to bearish technicals and low market cap, presenting high volatility risks. Key opportunities include potential growth from increased adoption, but major risks involve low liquidity and regulatory uncertainties. Investors should monitor trading volume and on-chain activity closely.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Injective
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →About Saros
Saros is a digital identity platform and super app on the Solana blockchain. It started with the SarosSwap decentralized exchange and has grown into a full Web3 ecosystem. Its non-custodial wallet features Social Login, Watch-only mode, and an NFC hybrid wallet for better security and convenience. The wallet integrates with SolanaPay, facilitating efficient transactions through an in-house payment module.
Read more on SAROS →
